Category: Resyndicated

USDA Wants Deceptively Cute Images For GMO Labels, But Cuts The Phrase “Genetically Modified”

(Natural Blaze) The public comment period is now open on the U.S. Department of Agriculture’s just unveiled proposal for food labeling of products using GMOs—a plan that would have labels without the words “genetically modified” or “genetically engineered,” but instead adorned with cheerful images.

The images are just as insulting to consumers as the law, which the chemical and junk food industry lobbyists spent $400 million to pass.” –Katherine Paul, Organic Consumers Association

According to Wenonah Hauter, executive director of Food & Water Watch, the proposal represents “a gift to industry from our now Secretary of State, Mike Pompeo, who authored the legislation to squash the Vermont GMO labeling law and mandatory labels.”

The proposal follows President Barack Obama’s 2016 signature on an industry-approved bill—dubbed the DARK Act—that required national labeling standard rules, and which critics blasted for having loopholees and lacking a mandate for adequate GMO labels. That law, which pre-empted Vermont’s first-of-its-kind labeling law, also required a deadline for the final rules by July 29, 2018, hence the USDA’s rollout this week.

Among the problems with the proposal, says Hauter, is that the “rule refers to GMOs as ‘bioengineered,’ or BE foods. This is a deceptive strategy because most consumers don’t know what that means.”

Andrew Kimbrell, executive director at Center for Food Safety, agreed, saying, “USDA’s exclusion of the well-established terms, GE and GMO, as options will confuse and mislead consumers, and the agency must instead allow the use of those terms.”

As for the images that will bear the acronym BE—”Wait ’till you see them,” writes Katherine Paul, associate director of the Organic Consumers Association. “All bright and cheery, with sunburst and smiley-faced images—but without ‘GMO’ appearing anywhere on the labels.”

“The images are just as insulting to consumers as the law, which the chemical and junk food industry lobbyists spent $400 million to pass—under the specious name of the ‘Safe and Affordable Food Labeling Act,’” Paul said.

The problems go beyond the symbol, say food safety groups.

“One of the many loopholes,” Hauter added, is that it “would allow a company that knowingly sells canned GMO sweetcorn to use a label that says ‘may be bioengineered’ because less than 85 percent of sweetcorn grown is genetically engineered.”

In addition, it would allow companies to use electronic QR codes, instead of a clear symbol, which would necessitate consumers having a clear internet connection, a smart phone, and the time for the hassle it would take to scan them.

“USDA should not allow QR codes,” Kimbrell said bluntly. “USDA’s own study found that QR codes are inherently discriminatory against one third of Americans who do not own smartphones, and even more so against rural, low income, and elderly populations or those without access to the internet. USDA should mandate on-package text or symbol labeling as the only fair and effective means of disclosure for GE foods.”

In sum, the groups say, the proposal leaves consumers in the dark.

“This is a ‘Call to Action’ to all Americans who have waited for decades to finally have GE foods labeled,” says Kimbrell. “Now is the time to tell the Trump administration to do the right thing and meaningfully label these foods.”

This article (USDA Wants Deceptively Cute Images for GMO Labels, But Cuts the Phrase Genetically Modified) appeared first at Common Dreams and is licensed under a Creative Commons Attribution-Share Alike 3.0 License. (Image: Organic Consumers Association)

Most University Medical Research Brought To You By Big Pharma

(Natural Blaze by Brandon Turbeville) Partly a result in the decrease in government funding in innovation, health, science, and general development and partly a result of the close connection between major corporations, government, and academia, there has been a major increase in the “financial partnerships” between universities and Big Pharma over the past several years. Once a relatively rare occurrence, Big Pharma/Big Ed partnerships have become a common sight, with many corporations maintaining massive “integrated programs” and “science hubs” in university institutions. The focus of these programs are not necessarily public health but the development of drugs for Big Pharma profits.

GlaxoSmithKline at Harvard, AstraZeneca at the University of Washington, and Pfizer at the University of California are some of the most glaring examples, but they are by no means even the tip of the iceberg in Big Pharma/Big Ed partnerships. As SOTT.net writes in its article “Big Pharma Pays Universities For Most Medical Research In the United States,

In fact, with the increasing financial ties between academia and the pharmaceutical industry, many drug companies have formed specialized divisions that are solely responsible for seeking research and development relationships with academic institutions.”

Related: Doctors Against Vaccines – Hear From Those Who Have Done the Research

One such reason for a greater reliance on Big Pharma for research money is the decline in interest of the U.S. government to fund projects that would theoretically benefit human health and increase living standards through progress and development. For instance, a report in the British Medical Journal stated that “An estimated 60% of biomedical research and development in the United States is now privately funded, and two thirds of academic institutions have equity ties with outside sponsors.” In other words, over half of the medical research conducted at universities is conducted with funding from Big Pharma itself.

A review published in the Mens Sana Monograph suggests that,

This need for large funds is, moreover, coupled with the desire to acquire it without making a dent in one’s own pockets. The easiest way that can happen is getting an interested party to fund it, which has a big stake in the success of the entire venture. Hence, the pharmaceutical industry becomes a willing partner in the whole enterprise.

Related: The MMR Vaccine – A Comprehensive Overview of the Potential Dangers and Effectiveness

The Washington Post, surprisingly, explains one reason such heavy corporate funding is a bad idea. It states,

The billions that the drug companies invest in such experiments help fund the world’s quest for cures. But their aim is not just public health. That money is also part of a high-risk quest for profits, and over the past decade corporate interference has repeatedly muddled the nation’s drug science, sometimes with potentially lethal consequences

Ever since the 1980s, more money for medical research has come from Big Pharma than from grants awarded by the NIH. In 2011, Big Pharma spent $39 billion while the NIH only spent $31 billion. This is in part a testament to the fact that, while the U.S. can waste billions on foreign wars and foreign aid, it is pinching pennies with research that could benefit its own people back home. But it’s also a revelation of just how close corporate interests and the University Industrial Complex actually are. Thus, it’s very concerning when one of the greatest forces for cultural “revolution” and Big Pharma are teaming up to such an openly high level.

Editor’s Note: “Industry-sponsored clinical trials are four times more likely to report positive results than non-industry sponsored clinical trials.”

In addition, SOTT writes of how this growing partnership raises some serious conflict of interest questions. The website writes,

It is no secret that relationship between doctors and pharmaceutical companies has involved significant financial entanglement, consequently opening a debate on conflict of interest issues.4 Financial incentives provided by drug companies have influenced doctors to engage in inappropriate prescribing habits to promote the purchase and use of the sponsoring company’s drug, thus questioning the credibility of both parties involved.4

This same type of cozy relationship is now becoming prominent between academics and pharmaceutical companies. While financial relationships between doctors and drug companies has come under significant scrutiny, less attention is being paid to financial relationships between academics and the drug industry.4

There is enough evidence to document conflict of interest issues between academics in leadership positions and the drug industry. A study published in the Journal of the American Medical Association reveals:

Almost every major U.S.- based pharmaceutical company in 2012-and nearly 40 percent worldwide-had at least one board member in a leadership position from a U.S. academic medical center, raising potentially problematic conflict-of-interest questions. The board members were compensated an average of $312,564 by the pharmaceutical companies, while concurrently holding clinical or administrative leadership positions at academic medical centers.6

The study’s senior author, Welld Gallad, MD, MPH points out:

[P]harmaceutical industry board membership by academic medical center leaders could lead to a different kind of potential conflict of interest, since academic leaders wield considerably more influence over research, clinical and educational missions than ordinary physicians or staff who may be targeted for gifts by pharmaceutical representatives.6

Scientifically Proven Method to Reverse Diabetes (Ad)

Dr. Gallad adds:

The public will have to decide whether these non-profit, and in many cases publicly funded, academic institutions can manage these potential conflicts with internal policies, or whether additional regulation is needed.6

. . . . .

A significant amount of vaccine related research is now being conducted at American academic institutions. Many universities now have their own vaccine research centers, with pharmaceutical companies funding many of the studies. Professors and other academic scientists who conduct these studies often also have personal financial relationships with vaccine manufacturers. This conflict of interest may or may not be revealed in the study’s original publication, depending upon the medical journal in which the study is published.

Concerns have been voiced about the pharmaceutical industry’s lack of transparency with regard to the development and side effects of FDA licensed drugs and vaccines and financial relationships with the medical profession, which promotes the use of those drugs and vaccines. It is logical to ask whether the public can trust the conclusions of vaccine research conducted by academic institutions heavily funded by vaccine manufacturers, which may incentivize researchers to steer research toward conclusions that suit the financial interests of those companies.

One does not need to look too far in order to see that the University research/Big Pharma partnership is creating a dangerous culture. Many academics survive on grants either by government or by corporations and a researcher might be ending his own career if he bucks the institution which is paying for the gravy train. This is one reason university scientists, researchers, and academics are some of the most vociferous guard dogs and defenders of corporations. With Big Pharma paying the bills of most medical research conducted in the United States, there is no wonder why Big Ed is simply becoming the validator of industry science in the sickest nation on the planet. Come to think of it, there is no wonder why the United States is the sickest nation on the planet.

Hat tip to SOTT “Big Pharma Pays Universities For Most Medical Research In The United States”

China No Longer Accepting World’s Garbage, Time For A National Recycling Program

(Natural Blaze by Brandon Turbeville) In 2017, China announced that it would no longer be accepting much of the world’s trash in the coming year. In January, it followed through with that announcement and stopped accepting 24 types of waste which includes plastics, mining slap, garbage textiles, and plastics. China’s stated reason for no longer accepting the waste is its own concerns over pollution domestically.

This new policy has caused shockwaves in the United States, Ireland, Germany, Canada, and a number of European countries who are now rushing to figure out a solution to their growing piles of trash that had previously just been sent overseas.

If sanity were to prevail of course, the United States and fellow countries would immediately begin developing methods of recycling and industries/services to do just that domestically. A national recycling program would be a perfect solution that would not only recycle the material that is now piling up but also clean up the American environment and create good-paying jobs.

In other words, a national recycling program funded by low- to zero-percent interest credit from a nationalized Federal Reserve that would see the entire country’s garbage recycled and sold at a profit as well as the recycling of material already buried in landfills.

Instead, however, the United States is attempting to force China to accept its trash by using the World Trade Organization’s enforcement mechanism for the “Free Trade” and the “Global Economy” that has ruined the living standards of virtually every country that has embraced it. The U.S. is arguing that China’s new policy is causing a “fundamental disruption in global supply chains for scrap materials.”

As Reuters reported,

“China’s import restrictions on recycled commodities have caused a fundamental disruption in global supply chains for scrap materials, directing them away from productive reuse and toward disposal,” a U.S. representative told the meeting, according to a trade official in Geneva.

[…]

We request that China immediately halt implementation and revise these measures in a manner consistent with existing international standards for trade in scrap materials, which provide a global framework for transparent and environmentally sound trade in recycled commodities.”

Fix your vision naturally without glasses (Ad)

But sanity is not something the WTO is known for enforcing. Still, China is defending its policy, however. As EcoWatch reports:

The concerns are neither reasonable nor have any legal basis,” Foreign Ministry spokesperson Hua Chunying said at a daily press briefing in response to the U.S. official’s remark.

“It’s very hypocritical of the U.S. to say China is breaching its WTO duty,” Hua said. She noted that if the U.S. thought it legitimate to restrict exports of high-tech and high-value-added products, then China’s ban on foreign waste imports was not illegal.

“Restricting and banning the imports of solid waste is an important measure China has taken to implement the new development concept, improve environmental quality and safeguard people’s health,” Hua said, adding that the Basel Convention allows countries the right to restrict the entry of foreign waste.

“We hope that the U.S. can reduce and manage hazardous waste and other waste of its own and take up more duties and obligations.”

Organic Agriculture Is Going Mainstream, But Not The Way You Think It Is

(The Conversation) One of the biggest knocks against the organics movement is that it has begun to ape conventional agriculture, adopting the latter’s monocultures, reliance on purchased inputs and industrial processes.

“Big Organics” is often derided by advocates of sustainable agriculture. The American food authors Michael Pollan and Julie Guthman, for example, argue that as organic agriculture has scaled up and gone mainstream it has lost its commitment to building an alternative system for providing food, instead “replicating what it set out to oppose.”

New research, however, suggests that the relationship between organic and conventional farming is more complex. The flow of influence is starting to reverse course.

Practitioners of conventional agriculture are now borrowing “organic” techniques to reduce the use of pesticides, artificial fertilizers and excessive tillage, and to increase on-farm biodiversity, beneficial insects and soil conservation.

All of a sudden, many conventional vegetable farms are starting to look organic.

Organic goes mainstream

Next to nothing has been written on this subject. A rare exception is a 2016 article in the New York Times that profiled conventional farmers in Indiana who had started to use “cover crops.”

These non-commercial crops build organic matter into the soil, fix atmospheric nitrogen and add biodiversity to an agroecosystem, while allowing farmers to reduce artificial fertilizer inputs.

As organic agriculture has scaled up, it has gained credibility in the marketplace as well as on the farm. Organic farming has roots in market gardens and smaller farms, but there is nothing that prohibits organic production at larger scales.

That often means bigger farms, hundreds — or thousands — of acres in size.

This move toward the mainstream has caught the eye of many conventional farmers, who have either transitioned to certified organic production or begun to integrate organic practices on conventional plots.

Market share not the whole story

Even with the upscaling, the market position of organic agriculture remains limited.

In Canada, organic sales grow by nearly 10 per cent per year, and the total value of the organic market is around $5.4 billion. Yet the reality is that the industry is still dwarfed by conventional agriculture.

There are more than 4,000 certified organic farms in Canada, totalling 2.43 million acres. But this accounts for only 1.5 per cent of the country’s total agricultural land.

Also, aside from the two organic heavyweights — coffee (imported) and mixed greens (mostly imported) — the market share of organic groceries is pretty small, at around three per cent.

Yet the influence of organics is felt well beyond its own limited market.

Testing the market

Many growers divide their farms into separate conventional and certified organic zones. This “split production” is a way to learn organic growing, test the market and hedge one’s bets against yield issues.

In 2017, as part of a research project on organic transition funded by the Canadian Organic Growers (COG), I travelled across the country and conducted in-depth interviews at farms that had recently transitioned from conventional to organic farming.

Half of the 12 farms I visited practised split production. What’s significant (and totally unanticipated) is that all of the farms in split production had also introduced organic techniques to the conventional portions of the operation.

With familiarity came trust.

Adopting organic techniques

These are not mom-and-pop operations. The list includes Canada’s biggest organic vegetable operation — Kroeker Farms/PoplarGrove in Winkler, Manitoba — and many other large vegetable farms across the country.

They used compost, manure and/or cover crops, had cut back on toxic and persistent pesticides, reduced tillage and embraced longer and more biodiverse crop rotations. In the process, they had also protected and promoted pollinators and beneficial insect predators.

Kroeker Farms, a megafarm that has 4,800 acres under organic production and another 20,000 or so in conventional production, is leading the trend toward a more organic-like conventional system.

“We try really, really hard to use organic-type pesticides or biological [control agents] in our conventional because once you spray with a more lethal spray that’s a broad spectrum [pesticide], the pests flare up after that,” the CEO of the company, Wayne Rempel, told me.

Trending nationally

Similar trends are found across the country.

In Prince Edward Island, Red Soil Organics has begun to plant fall rye — a classic organic cover crop — as part of the rotation on its conventional side, a bit like those farmers in Indiana.

Another PEI farm, Square One Organics, uses cover crops, manure and tine weeding (a common, low-impact, mechanical weeding technique used on organic farms) on their conventional plots.

The cover crops and manure have allowed the farm to reduce its use of nitrogen fertilizer by about 10 per cent. This reduces nitrogen runoff into waterways, which can cause algae blooms and kill aquatic species.

The combination of tine weeding and perennial cover crops has also allowed the farm to reduce or eliminate herbicide use on the conventional side of the farm. “We’re managing our soil organic matter in totally different ways,” says owner Matt Ramsay.

It’s impossible to know the cumulative ecological benefits of this growing trend. Organic techniques, such as composting and the use of cover crops, are not tracked closely by Statistics Canada. With more research, we might have a better sense of the benefits.

Grounds for action

The motivations are easier to define. Farmers have made it clear that organic techniques work well, organic inputs are generally cheaper than conventional ones, and organic practices have a beneficial impact on the agroecosystem.

Yet until a conventional farmer begins the transition to certified organic growing, he or she often knows or cares little about organic practices. Right now, the best way for a farmer to learn about organic growing is by reading handbooks, attending conferences and taking courses.

The ConversationIt might be the case that Big Organics has begun to look like conventional farming. But it appears to be the case that, at least on some Canadian farms, Big Conventional is starting to look like organic.

Jeremy Lawrence Caradonna, Adjunct Professor of Environmental Studies, University of Victoria

Supplements for BPA and BPS, Heavy Metal Detox, and Other Endocrine Disrupters

Without a proper diet, the right supplements will work, but only to a certain extent, and only for a little while. On the other hand, supplements taken with a healthy diet can radically speed up healing time.

This article is an excerpt from How to Detox From Plastics and Other Endocrine Disruptors

Probiotics

1.) Get thee some probiotics – pronto. I’m not talking celebrity endorsed yogurt here. Chose fermented foods like kimchi, natural sauerkraut, and kefir. A refrigerated, concentrated probiotic supplement helps. Drink kombucha. Bifidobacterium breve and Lactobacillus casei were found to extract BPA from the blood of mammals and were excreted out through the bowels. That is very good news!

Beneficial bacteria strengthen the gut and help break down chemicals like BPA so they can be cleared out. As a bonus, they break down pesticides, another major endocrine-disruptor, and other toxins as well. Probiotics are becoming well known for breaking down endocrine-disruptors and other toxins in the body.

Chlorella has a well-documented history of helping remove heavy metals and other toxins like dioxin from the body expeditiously. Its high concentration of chlorophyll and fiber seems to be a big part of its exceptional detox benefits. It’s almost certain, considering the mechanism, that Chlorella (and spirulina) help pull out BPAs and other plastic residue.

Chlorella is a good source of protein, GLA, and phytochemicals, B12, B2, B3, iron, magnesium, Beta Carotene, and a bunch of powerful phytochemicals. Chlorella stimulates the growth of friendly bacteria. Furthermore, chlorella’s cell walls act to absorb toxic compounds within the intestines, restoring proper gastrointestinal pH and helping to promote normal peristalsis. And it is another chelator, as it is also very negatively charged, attracting positively charged molecules.

Phytochemicals found within Chlorella pyrenoidosa support the complex network of enzymatic reactions that drive the human detoxification system. This detoxification network involves the Phase I and Phase II enzymatic reactions that take place in nearly all cells in the body, though they are concentrated in the liver cells. Phase I detoxification reactions change non-polar chemicals that are not water-soluble into relatively polar, water-soluble compounds. The Phase I process can result in the formation of reactive chemicals that are typically more toxic than the original compounds. Phase II detoxification is necessary therefore to add chemical groups to the toxic intermediates to make them water-soluble so that they may easily be excreted via urine and/or feces. Phase I and Phase II detoxification pathways must remain functional for the removal of toxins from the body. This research focuses specifically on the Chlorella pyrenoidosa species of green algae recognized for its detoxification properties. – King Hardt Academy

Spirulina

Chlorella is green algae, but spirulina is more of a blue-green in color. These two algae have a lot in common. Chlorella’s green hue demonstrates that it’s richer in chlorophyll than spirulina, and chlorella is said to have stronger detoxification properties. But spirulina is an even better source of protein, and it offers iron, B1, B2, B3, B6, B12, calcium, potassium, zinc, and a host of microminerals.

Related: Total Nutrition – Make your own Homemade Multivitamin and Mineral Formula

Enzymes

Digestive enzymes break down food. Metabolic enzymes, also known as systemic enzymes, break down foreign proteins, fibrin, and other toxins, and they clean the blood of impurities. Consider the ramifications of this. Probiotics and enzymes together help breakdown nearly everything in the gut that doesn’t belong. Read more about systemic enzymes here.

Green Tea

One way in which BPA harms body tissues is through oxidative stress. Two laboratory studies using extracts from both green tea and black tea were able to mitigate the damaging effects of BPA by protecting our cells from oxidative damage. Green tea has also been shown to stimulate glucuronidation, a detoxification pathway used for eliminating BPA from the body.

Lipoic Acid and folate have also been shown to reverse many of BPAs most damaging effects, especially oxidative stress.